Diagnosing and Treating Immune Thrombocytopenic Purpura
The group continues their analysis of emergencies by exploring their first hematologic emergency: Immune thrombocytopenic purpura (ITP). They explain how to confirm that the diagnosis is in fact ITP, and subsequently, provide a treatment plan.
EMBER-3 Trial: Imlunestrant Improves PROs in ER+/HER2– Breast Cancer
Oral Paclitaxel Non-Inferior to IV Paclitaxel in HER2-Negative mBC
DESTINY-Breast06: T-DXd Outperforms Chemo in HER2-Low/Ultralow HR+ mBC Across Mutations